Posted by Michael Wonder on 30 Jun 2020
Schedule of Pharmaceutical Benefits - 1 July 2020
1 July 2020 - The July 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The July issue of the Schedule includes a small number of new/revised listings:
- Alectinib hydrochloride (Alecensa) - restriction change
- Azetolizumab (Tecentriq) - new strength & restriction change
- Ceritinib (Zykadia) - restriction change
- Crizotinib (Xalkori) - restriction change
- Semaglutide (Ozempic) - new medicine
